CURIS INC
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 128 SPRING STREET, LEXINGTON, MA, 02421
Mailing Address 128 SPRING STREET, LEXINGTON, MA, 02421
Phone 617-503-6500
Fiscal Year End 1231
EIN 043505116
Financial Overview
FY2024
$77.28M
Total Assets
$57.61M
Total Liabilities
$26.68M
Cash & Equivalents
$-6.88
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-3 Shelf registration for future offerings | February 13, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | January 23, 2026 | View on SEC |
| 8-K Current report of material events | January 8, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | November 14, 2025 | View on SEC |
| 8-K/A Current report amendment | November 13, 2025 | View on SEC |
| 8-K Current report of material events | November 6, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 6, 2025 | View on SEC |
| 8-K Current report of material events | October 24, 2025 | View on SEC |
| 8-K Current report of material events | August 22, 2025 | View on SEC |
Material Events
8-K Legal Issue February 9, 2026
High Impact
- CURIS INC successfully secured its continued listing on the Nasdaq Global Market, avoiding delisting.
- The company regained full compliance with Nasdaq's Market Value of Listed Securities (MVLS) Rule.
Related Companies
Companies in the same industry (SIC: 2836)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.